Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles. Chittasupho C*, Lirdprapamongkol K, Kewsuwan P, Sarisuta N. Eur J Pharm Biopharm. 2014 Oct;88(2):529-38.

01 Oct 2014
0

Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles.

Chittasupho C*, Lirdprapamongkol K, Kewsuwan P, Sarisuta N.

Eur J Pharm Biopharm. 2014 Oct;88(2):529-38.

Tags

Share this

Related Posts

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)